within Pharmacolibrary.Drugs.ATC.A;

model A16AA01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0.07266666666666667,
    adminDuration  = 600,
    adminMass      = 2.0,
    adminCount     = 1,
    Vd             = 0.00057,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Levocarnitine (L-carnitine) is a naturally occurring amino acid derivative that facilitates the transport of long-chain fatty acids into mitochondria for beta-oxidation. It is used in the treatment of primary and secondary carnitine deficiency in adults and children, and is approved for conditions such as end-stage renal disease on hemodialysis, inborn errors of metabolism, and other conditions where carnitine deficiency has been diagnosed.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult volunteers after single intravenous dose.</p><h4>References</h4><ol><li>Allan M Evans, Gianfranco Fornasini,Pharmacokinetics of L-carnitine.,Clinical pharmacokinetics,2003<a href='https://pubmed.ncbi.nlm.nih.gov/12908852/'>https://pubmed.ncbi.nlm.nih.gov/12908852/</a></li><li>P R Borum,Carnitine.,Annual review of nutrition,1983<a href='https://pubmed.ncbi.nlm.nih.gov/6357236/'>https://pubmed.ncbi.nlm.nih.gov/6357236/</a></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end A16AA01;
